Zacks Research Analysts Lift Earnings Estimates for ALLO
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Analysts at Zacks Research upped their Q1 2025 EPS estimates for shares of Allogene Therapeutics in a research note issued to investors on Wednesday, April 2nd. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of ($0.31) for the quarter, up […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Analysts at Zacks Research upped their Q1 2025 EPS estimates for shares of Allogene Therapeutics in a research note issued to investors on Wednesday, April 2nd. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of ($0.31) for the quarter, up […]